Douglas Elliman Inc
NYSE:DOUG
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Douglas Elliman Inc
Accrued Liabilities
Douglas Elliman Inc
Accrued Liabilities Peer Comparison
Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
D
|
Douglas Elliman Inc
NYSE:DOUG
|
Accrued Liabilities
$35.1m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Jones Lang LaSalle Inc
NYSE:JLL
|
Accrued Liabilities
$1.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
10%
|
|
C
|
Compass Inc
NYSE:COMP
|
Accrued Liabilities
$142.2m
|
CAGR 3-Years
7%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
CBRE Group Inc
NYSE:CBRE
|
Accrued Liabilities
$2.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
11%
|
|
Zillow Group Inc
NASDAQ:ZG
|
Accrued Liabilities
$178m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
10%
|
CAGR 10-Years
25%
|
|
Newmark Group Inc
NASDAQ:NMRK
|
Accrued Liabilities
$532.1m
|
CAGR 3-Years
11%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
See Also
What is Douglas Elliman Inc's Accrued Liabilities?
Accrued Liabilities
35.1m
USD
Based on the financial report for Dec 31, 2023, Douglas Elliman Inc's Accrued Liabilities amounts to 35.1m USD.
What is Douglas Elliman Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 3Y
-1%
Over the last year, the Accrued Liabilities growth was -13%. The average annual Accrued Liabilities growth rates for Douglas Elliman Inc have been -1% over the past three years .